This suggests that NSCLC patients with high infiltration of CD8+ T cells and low infiltration of CD8+PD-L1+ T cells or high infiltration of CD8+ T cells and low infiltration of CD68+CD163+ M2 macrophages were more likely to respond to ICIs than patients with other biomarker patterns. Here, CD163 is linked to non-small cell lung carcinoma.